RT Journal Article
SR Electronic
T1 Application of the Logistic Model to the COVID-19 Pandemic in South Africa and the United States: Correlations and Predictions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.12.22269193
DO 10.1101/2022.01.12.22269193
A1 David H. Roberts
YR 2022
UL http://medrxiv.org/content/early/2022/01/19/2022.01.12.22269193.abstract
AB We apply the logistic model to the four waves of COVID-19 taking place in South Africa over the period 3 January 2020 through 14 January 2022. We show that this model provides an excellent fit to the time history of three of the four waves. We then derive a theoretical correlation between the growth rate of each wave and its duration, and demonstrate that it is well obeyed by the South African data.We then turn to the data for the United States. As shown by Roberts (2020a, 2020b), the logistic model provides only a marginal fit to the early data. Here we break the data into six “waves,” and treat each one separately. Five of the six can be analyzed, and we present full results. We then ask if these data provide a way to predict the length of the ongoing Omicron wave in the US (commonly called “wave 4,” but the sixth wave as we have broken the data up). Comparison of these data to those from South Africa, and internal evaluation of the US data, suggest that this current wave will peak about 18 January 2022, and will be substantially over by about 11 February 2022. The total number of infected persons by the time that the Omicron wave is completely over is projected be between 22 and 24 million.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://covid19.who.int/WHO-COVID-19-global-data.csv Funding StatementThis research received no funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWHO COVID-19 Website https://covid19.who.int/WHO-COVID-19-global-data.csv